When UK-396082 was administered in conjunction with Ang II, there was an increase in the incidence of AAA at 28 days, however, once the reduced rate of rupture in this group was taken into account, there was no overall change in Ang II response, a result that is more in keeping with the previous study in the TAFI-/- mouse [19]. This evidence concerns the gene AGT and triple-A syndrome.